SPCS3
Signal peptidase complex subunit 3
Also known as: FLJ22649, PRO3567, SPC22/23, SPC3, SPCS3_HUMAN, YLR066W
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P61009
- Gene
- SPCS3
- Ensembl
- ENSG00000129128
- Chromosome
- 4
- Canonical length
- 180 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins
OverviewNCBI Gene
Involved in signal peptide processing and viral protein processing. Located in endoplasmic reticulum membrane. Part of signal peptidase complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
180 residues, UniProt reviewed canonical sequence.
>P61009|SPCS3
1 MNTVLSRANS LFAFSLSVMA ALTFGCFITT AFKDRSVPVR LHVSRIMLKN VEDFTGPRER
61 SDLGFITFDI TADLENIFDW NVKQLFLYLS AEYSTKNNAL NQVVLWDKIV LRGDNPKLLL
121 KDMKTKYFFF DDGNGLKGNR NVTLTLSWNV VPNAGILPLV TGSGHVSVPF PDTYEITKSYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SPCS3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 93 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 93 nTPM
- pancreas: 68 nTPM
- bone marrow: 64 nTPM
- thyroid gland: 58 nTPM
- appendix: 48 nTPM
- lymph node: 47 nTPM
Single-cell type
- plasma cells: 825 nCPM
- esophageal apical cells: 320 nCPM
- extravillous trophoblasts: 269 nCPM
- pancreatic acinar cells: 245 nCPM
- salivary acinar cells: 243 nCPM
- syncytiotrophoblasts: 233 nCPM
Immune cell
- basophil: 43 nTPM
- plasmacytoid DC: 23 nTPM
- MAIT T-cell: 20 nTPM
- intermediate monocyte: 19 nTPM
- total PBMC: 19 nTPM
- NK-cell: 17 nTPM
Brain region
- midbrain: 56 nTPM
- white matter: 46 nTPM
- spinal cord: 40 nTPM
- hypothalamus: 37 nTPM
- cerebral cortex: 37 nTPM
- thalamus: 35 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SPCS3.
Disease | ImmuneIEDB
Conditions an epitope on SPCS3 was assayed in.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.53
- gnomAD pLI
- 0.82
- gnomAD missense Z
- 2.04
- DepMap mean gene effect
- -1.08
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Signal peptidase complex subunit 3
- Signal peptidase subunit
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SPCS3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SPCS3 as an antibody target. Whether an autoantibody or antibody against SPCS3 could matter depends on whether native SPCS3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SPCS3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SPCS3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...